Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA

Lenexa, Kansas, USA facility becomes company’s largest dry powder cell culture media facility and Center of Excellence  in North America Boos...

July 13, 2023 | Thursday | News
Silence Therapeutics Earns $4M Milestone Payment from Hansoh Pharma Collaboration

“We are very pleased with the continued progress being made in our Hansoh Pharma collaboration,” said Craig Tooman, President and CEO of Silenc...

July 12, 2023 | Wednesday | News
MaxCyte and Vittoria Biotherapeutics Sign Strategic License for Next-Gen Cellular Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...

July 11, 2023 | Tuesday | News
Hillstream BioPharma Reprioritizes Pipeline to Target HER2/HER3 Solid Tumors

Lead bispecific antibody, HSB-3215 designed to target novel conformational epitopes on high value validated targets, HER2 and HER3 Focus on optimizing ADC...

July 11, 2023 | Tuesday | News
INOVIQ and Promega announce global marketing agreement for EXO-NET exosome solutions

INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purificati...

July 07, 2023 | Friday | News
Carrick Therapeutics collaborates with Arvinas and Pfizer for clinical trial on Samuraciclib and Vepdegestrant combination

Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced a clinical ...

July 07, 2023 | Friday | News
Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeuti...

July 06, 2023 | Thursday | News
InnoCare Initiates Psoriasis Clinical Trial of ICP-488 in China

In phase I clinical trial, the single ascending doses (SAD) and multiple ascending doses (MAD) have been completed with ICP-488, demonstrating well-tolerat...

July 05, 2023 | Wednesday | News
Camena Bioscience Raises $10M in Series A Funding Amid Growing DNA Synthesis Demand

Funding will be used to scale operations and continue development of its pioneering DNA synthesis platform, gSynth™ Funding round led by Mercia C...

July 04, 2023 | Tuesday | News
Organon & Samsung Bioepis Launch HADLIMA™ Biosimilar of HUMIRA in the US

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” ...

July 03, 2023 | Monday | News
Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies

The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to the Saphyr® i...

June 30, 2023 | Friday | News
Thermo Fisher Scientific Launches Cancer Treatment-Enabling Tumor Culture Medium

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

June 29, 2023 | Thursday | News
Theriva Biologics Receives FDA Orphan Drug Designation for VCN-01 in Pancreatic Cancer Treatment

In VIRAGE, the ongoing multinational Phase 2b clinical study, intravenous VCN-01 is being evaluated in combination with standard-of-care (SoC) chemotherapy...

June 28, 2023 | Wednesday | News
Antibody-Drug Conjugates Clinical Trial Pipeline Gains Momentum with 180+ Companies: DelveInsight.

DelveInsight's 'Antibody-drug Conjugates Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

June 27, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close